Enliven Therapeutics, Inc.
ELVN
$21.00
$0.442.14%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 63.64% | 57.02% | -9.66% | 23.82% | 10.76% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 0.18% | -9.92% | -28.28% | 57.10% | -0.37% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -99.46% | -- |
| Total Current Assets | 62.52% | 55.79% | -12.72% | 19.53% | 10.57% |
|
|
|||||
| Total Current Assets | 62.52% | 55.79% | -12.72% | 19.53% | 10.57% |
| Net Property, Plant & Equipment | 38.73% | 29.71% | 14.18% | -56.87% | -47.67% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -6.22% | -10.90% | 54.64% | 54.17% | 84.42% |
| Total Assets | 60.72% | 54.07% | -11.73% | 19.82% | 11.45% |
|
|
|||||
| Total Accounts Payable | 40.24% | 117.08% | -42.72% | 152.26% | -31.75% |
| Total Accrued Expenses | -18.84% | 9.32% | 2.52% | -2.01% | 58.88% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 355.29% | 122.49% | 44.84% | -- | -74.40% |
| Total Finance Division Other Current Liabilities | -60.19% | -99.34% | -98.60% | -98.03% | -41.30% |
| Total Other Current Liabilities | -60.19% | -99.34% | -98.60% | -98.03% | -41.30% |
| Total Current Liabilities | -13.96% | -31.19% | -44.18% | -38.54% | 40.96% |
|
|
|||||
| Total Current Liabilities | -13.96% | -31.19% | -44.18% | -38.54% | 40.96% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -13.36% | -30.28% | -43.05% | -38.70% | 38.51% |
|
|
|||||
| Common Stock & APIC | 56.04% | 56.51% | 13.21% | 38.24% | 28.08% |
| Retained Earnings | -44.13% | -50.84% | -53.52% | -57.64% | -63.09% |
| Treasury Stock & Other | -8.68% | -27.34% | 69.81% | -60.99% | 264.63% |
| Total Common Equity | 65.09% | 60.19% | -9.26% | 26.00% | 10.18% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 65.09% | 60.19% | -9.26% | 26.00% | 10.18% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 65.09% | 60.19% | -9.26% | 26.00% | 10.18% |
|
|
|||||